Men's Renal & Urology Health Update

Men’s Health Update

MEN’S HEALTH UPDATE

Q&A: Monoclonal Antibodies for COVID-19

The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
Next post in Men's Health Update